Pfizer-BioNTech announce positive topline results of pivotal COVID-19 vaccine study in adolescents

Business & Industry News Channel
Earlier today, the MHRA announced their review of the small number of thromboembolic events in over 11 million people who received COVID-19 Vaccine AstraZeneca in the UK.